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A number of cyclic peptides, including [FR]4, [FK]4, [WR]4, [CR]4, [AK]4, and [WK]n (n = 3-5)
containing L-amino acids were synthesized using solid-phase peptide synthesis. We hypothesized that an
optimal balance of hydrophobicity and charge could generate self-assembled nanostructures in aqueous
solution by intramolecular and/or intermolecular interactions. Among all the designed peptides, [WR]n (n
= 3-5) generated self-assembled vesicle-like nanostructures at room temperature as shown by
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), and/or Dynamic light
scattering (DLS). This class of peptides represents the first report of surfactant-like cyclic peptides that
self-assemble into nanostructures. A plausible mechanistic insight of self-assembly of [WR]5 was
investigated by molecular modeling studies. Modified [WR]5 analogues, such as [WMeR]5. [WR(Me)2]5,
[WMeR(Me)2]5, and [WdR]5 exhibited different morphologies than [WR]5 as shown by TEM observations.
[WR]5 exhibited significant stabilizing effect for generated silver nanoparticles and glyceraldehyde-3phosphate dehydrogenase activity. These studies established a new class of surfactant-like cyclic peptides
that self-assembled into nanostructures and could have potential applications for stabilizing of silver
nanoparticles and protein biomolecules.

1. Introduction
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Well-defined nanostructures have drawn significant attention in
the fields of biomedicine and biotechnology, material science,
and nanotechnology.1,2 The formation of ordered structures is
facilitated by different types of noncovalent interactions,
including electrostatic, hydrogen bonding, hydrophobic, and
aromatic stacking.3−5 In this context, self-assembly of peptides at
nanoscale has emerged as a subject of considerable interest in
recent years. Various types of peptide nanostructures have been
reported with applications in diverse fields, such as antibacterial
agents,6 neurological regeneration,7 and biosensors.8,9 Ghadiri et
al.10 showed that cyclic D,L-peptides composed of alternating Dand L- amino acid residues can self-assemble into nanotubes by
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forming antiparallel hydrogen bonds between homochiral amino
acid residues of adjacent rings.
Peptides have attracted much attention as an alternative to
traditional surfactants for studies of membrane proteins, because
of their tendency to augment the formation of ordered
supramolecular assemblies.11 There is an urgent need to develop
more suitable surfactants that can provide natural alternatives for
studying the membrane environment.Linear surfactant-like
peptides bearing hydrophilic and hydrophobic residues have
shown to act as membrane protein stabilizers.12 Moreover, it has
been reported that these peptides can spontaneously undergo selfassembly to form dynamic nanostructures in a pure solution,
similar as other lipids and surfactants12. Compared to linear
peptides, cyclic peptides have greater potential as stabilizing
agents due to their enhanced chemical and enzymatic stability.13
Microbial cyclic peptide surfactants have been previously
reported in the literature.14,15 Random discovery by screening and
challenges in production of these natural surfactants by synthetic
or genetic engineering methods have hindered further
development of these analogs. Thus, the applications of natural
cyclic peptides as surfactants and protein stabilizers remain less
explored. We hypothesized that self-assembled cyclic peptides
with stabilizing and surfactant properties can be designed
rationally. Herein, we report the discovery of nanosized
surfactant-like L-cyclic peptides and their potential application as
a new class of silver nanoparticle and biomolecule stabilizers. To
the best of our knowledge, this class of peptides represents the
Soft Matter, [year], [vol], 00–00 | 1

first report of surfactant-like cyclic peptides that self-assemble
into nanostructures. Furthermore, this is the first application of
any surfactant-like synthetic cyclic peptide as a stabilizer for
silver nanoparticles and an enzyme.
5
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2. Results and Discussion
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2.1. Self-Assembly of Peptides

10

15

A number of cyclic peptides, including [FR]4, [FK]4, [WR]4,
[CR]4, [AK]4, and [WK]5 (Fig. 1) containing L-amino acids were
synthesized using solid-phase peptide synthesis. These peptide
sequences were selected to consist of alternating hydrophobic and
positively charged residues or alternating neutral and positively
charged residues as controls. We hypothesized that an optimal
balance of hydrophobicity and charge could generate selfassembled nanostructures in aqueous solution by intramolecular
and/or intermolecular interactions. We have previously reported
that among all the synthesized cyclic peptides, amphipathic Lcyclic peptide containing tryptophan and arginine efficiently
delivered cargoes intracellularly.16
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group of arginine residues in [WR]4 could take part in hydrogen
bonding interactions. Other 5 cyclic peptides did not have optimal
combination of hydrophobic and positively-charged residues
required for self-assembly process.
Initial conventional-TEM imaging of [WR]4 (2 mM aqueous
solution) showed vesicle-like structures after 4 days (Fig. S1,
Supplementary information). Larger particles were observed by
using conventional TEM microscope after a prolonged
incubation.
Further evidence for the aggregation of [WR]4 was observed in
a concentration-dependent fluorescence study. At lower
concentrations, the fluorescence intensity was proportionally
increased (excitation 280 nm, emission 360 nm). However, the
intensity remained constant at a higher concentration of 1 mM
(Fig. S2). The results suggest that fluorescence-quenching occurs
at the concentration that is sufficiently high enough for aggregate
formation. Since the hydrophobicity of Trp is weak, this peptide
self-assembly occurs at a high concentration (i.e. ≥1 mM)
possibly through intermolecular hydrophobic interactions
between Trp residues.
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Fig. 1. Chemical Structures of synthesized cyclic peptides (F =
phenylalanine, R = arginine, K = lysine, W = tryptophan, C = cysteine, A
= alanine).
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All the cyclic peptides (2 mM) were dissolved in water and
their structural morphologies were investigated using
Transmission Electron Microscopy (TEM) after a few days.
Among all the designed peptides, [WR]4 (Fig. 1) generated selfassembled nanostructures after a specific incubation time at room
temperature. Six cyclic peptides had the combination of
positively-charged residues and other amino acids. The indole
ring of tryptophan in [WR]4 appears to play crucial role in selfassembly because of high hydrophobicity and generating
potential hydrophobic interactions. Moreover, the guanidine
2 | Soft Matter, [year], [vol], 00–00
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Fig. 2. (a) and (b) FE-SEM image of self-assembled structure of [WR]5 (2
mM) in water after 20 days; (c) CD spectra of [WR]n (100 µM) in water,
where n = 3-5; (d) TEM images of self-assembly of [WR]5 (100 µM) in
PBS after 48 h; (e) TEM images of [WR]5 (100 µM) in PBS after 12 days.

As a result of the unusual behavior of [WR]4, other derivatives
in this class ([WR]3 and [WR]5 (Fig. 1)) were synthesized and
evaluated to investigate whether the ring size has any effect in the
This journal is © The Royal Society of Chemistry [year]
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self-assembly process. Structural investigations of analogues of
[WR]3 and [WR]5 were accomplished by TEM. Vesicle-like
structures were formed for all compounds in this class. TEM of
[WR]3 demonstrated small structure sizes of ~100 nm after 14
days incubation. [WR]4 and [WR]5 exhibited larger structures (~
550 and 930 nm respectively) with much higher frequency (Fig.
S1).
Systematic studies on the self-assembly behavior of [WR]5
were carried out using different tools. Direct dissolution of the
peptide in water did not reveal any specific structures after 24 h.
TEM images showed the formation of a few micelle-like
structures after 48 h. Nanovesicle structures with a diameter
between 50 and 100 nm were clearly observed after 12 days (Fig.
S4). The formation of vesicles was also confirmed by Scanning
Electron Microscopy (SEM) after 20 days incubation (Fig. 2a,b).
SEM results clearly show self-assembly by aggregation of small
particles to the larger particles.
Zeta-potential measurement by dynamic light scattering (DLS)
showed that self-assembled [WR]5 and [WR]4 had positive ζ
potential values (+56.2 ± 7.62 mV) and (+31.4 ± 6.83 mV),
respectively, which further demonstrate the formation of the
positively charged surfaces by the guanidinium of R residues.
It is well known that the secondary structure of the peptides
plays a critical role on the self-assembly pattern. Thus, circular
dichroism (CD) was used to assess the secondary structure of
these peptides. CD spectra of aqueous solution of the peptides
[WR]n (n = 3-5, 100 µM) at 25 °C (Fig. 2c) revealed two negative
bands at approximately 202-205 nm, 214-216 nm and a positive
band around 229 nm. To estimate the secondary structure content,
CD spectra were analyzed using an estimation program.17 The
analysis showed that peptides [WR]n n = 3-5 to have 37.6-38.8%
random and 31.6-35.7% sheet component with the remaining
assigned to turn (12.4-12.5%) and helix (11.5-13.1%) (Table S1).
The CD spectra of [WR]n (n = 3-5) displayed a distinct minimum
of ellipticity around 202-205 nm, indicating that the peptides
exist mostly in random coil states. The appearance of negative
band around 214-216 nm and positive band at 229 nm is
attributed to the strong exciton coupling produced by the
aromatic chromophores of indoles tryptophan residues stacking
against one another.18 In addition, all peptides showed the strong
negative bands around 214-216 nm and positive band at around
190, which are characteristic of the formation of distorted β-sheet
structures. In general, the backbone-backbone intermolecular
hydrogen bonding interactions proceed through parallel or
antiparallel β-sheet like stacking arrangements in linear
peptides.10b The results indicate that the self-assembly of these
cyclic peptides is driven mostly by the hydrophobic force,
hydrogen bonding by partial β-structures, and/or π-π stacking
interactions between tryptophan residues. These data are
consistent with those obtained with the previously reported cyclic
peptides19 where the peptides did not show any specific
secondary structure, and they self assembled into bilayer
vesicular nanostructures. The CD spectra demonstrated a
significant increase in spectral elipticity of [WR]5 compared to
that
of
[WR]3
and
[WR]4,
suggesting
stronger
intramolecular/intermolecular interactions in this peptide. These
data are consistent with TEM exhibiting high population of
nanostructures formation by [WR]5. Considering these facts,
This journal is © The Royal Society of Chemistry [year]
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[WR]5 was chosen as a model peptide for further self-assembly
studies in detail.
Dynamic light scattering (DLS) was employed to identify the
self-assembled structures in solution by determining the size
distribution of structures. DLS results showed that the majority
(80%) of nanostructures of [WR]5 (100 µM) were found in the
size range of 150-250 nm after 14 days (Fig. S3, Supplementary
Information). Furthermore, it was observed that the size of the
vesicle structures became larger over time as confirmed by TEM
and SEM studies. This can be attributed to the fusion or
aggregation of two or more vesicles as observed in the SEM
image (Fig. S4, Supporting Information). This pattern of
aggregation resembled with traditional surfactants.
To get a better understanding of the impact of time on the
aggregation process, the time-dependent studies by DLS were
conducted for [WR]n (n = 3-5). The samples were prepared in
water at the concentration of (1 mM) and the size distribution was
evaluated on the first, third, and fourteenth day. The first day
presents the immediate size of the formed nanoparticles after
dissolving in water. Initially, the peptides will have interactions
with water. Additionally, intramolecular interactions contribute to
the size distribution at this stage. The intramolecular and water
hydrogen bonding interactions are generated mainly by the
appropriate functional groups, such as guanidine residues.
Subsequently, the size of nanoparticles was compared after 3
days. The self-assembly trend in a short period is mainly related
to the initial intramolecular interactions of peptide functional
groups followed by the intermolecular interactions. However, the
size distribution was also investigated after a relatively longer
period (14 days) to determine the behavior of nanoparticles after
a prolonged incubation time. At a longer period, it is expected
that intermolecular interactions are the dominant driving force of
self-assembly.
As depicted in Fig. 3, the majority of [WR]5 nanoparticles
were found in 319 ± 54 nm after 1 day. However, after 3 days, the
self-assembly triggered, and [WR]5 nanoparticles showed larger
particles (395 ± 53 nm). This trend was continued, and after 2
weeks as [WR]5 nanoparticles were observed in 543 ± 41 nm,
suggesting that time is a critical element for the size distribution
of nanoparticles. Similar pattern was observed for [WR]4
nanoparticles. The size of [WR]4 nanoparticles were found to be
306 ± 102 nm, 424 ± 46 nm, 641 ± 175 nm at days 1, 3, and 14,
respectively. However, [WR]3 displayed a completely different
pattern. [WR]3 nanoparticles started increasing from day 1 (241 ±
100 nm) to day 3 (352 ± 7 nm). However, the nanoparticles size
was decreased to 216 ± 0.01 nm after 2 weeks. Several factors
could be responsible for the collapsing of [WR]3 nanoparticles,
such as nanoparticles instability in the long term due to the small
ring size and insufficient intramolecular or intermolecular
interactions due to the high strain in the cycle, or inappropriate
orientation of amino acids in the structure of peptide for
interactions. Smaller ring size in [WR]3 leads to more puckered
and more cup like nonplanar structure of monomer which is less
suited for self assemblage. The conformation of monomer
dictates the differences in shapes of aggregated supramolecules.
These results suggest that although time is a critical element in
the size of nanoparticles, stability of the nanoparticles could
affect the self-assembly process in the long period.

Soft Matter, [year], [vol], 00–00 | 3
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These data demonstrated the effect of the ring size the
nanoparticles size. At day 1, [WR]3, [WR]4, [WR]5 were found to
be in 241 ± 100, 306 ± 102, and 319 ± 54 nm respectively. This
part of result showed that the number of involved amino acids is
an important element in the immediate size distribution of
nanoparticles since [WR]5 led to a larger size of nanoparticles
compared to that of [WR]3. However, [WR]4 nanoparticles were
measured to be in the size of 424 ± 46 nm compared to the size of
[WR]3 (424 ± 46 nm) and [WR]5 (395 ± 53 nm) after 3 days
incubation, suggesting that the ring size with 8 amino acids is
optimal for self-assembly. This trend was similar after 2 weeks as
[WR]4 nanoparticles (641 ± 175 nm) showed distinctly larger
nanoparticles than [WR]3 (215 ± 0.01 nm) and [WR]5 (543 ± 41
nm). These results indicate that a [WR] cyclic peptide with eight
amino acids has an optimal ring size for the maximal
intermolecular and intramolecular interactions after 14 days.
However, primary nanoparticles size at day 1 was found to be
ring size dependent.
Additional characterization data were provided for these
peptides, such as fluorescence spectroscopy (Fig. S17) and FTIR.
Because of the highly sensitive indole chromophore in the
structure of the tryptophan, this amino acid was used for its
intrinsic fluorescence studies. Three cyclic peptides such as
[WR]3, [WR]4, and [WR]5 (100 µM in H2O) were used for
fluorescence studies. The data showed higher fluorescence
intensity for peptide containing higher number of tryptophan
residues [WR]5.
ATR-FTIR was used to further characterize the peptide amide
bond in [WR]4. The spectrum of the dry powder of the peptide
mixture revealed a two amide-I stretching at 1654 and 1640 cm-1.
In general, antiparallel β-structures exhibit a principle β-sheet
amide-I stretching vibration maximum at 1630–1640 cm-1 with a
secondary absorption at a frequency normally 50–70 cm-1 higher.
The absence of the secondary absorption shows that [WR]4
adopts partially a parallel β-structure orientation. This result is
consistent with stacking observed from the self-assembly
simulations (Fig. 3).
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Fig. 3. DLS studies of [WR]n (n = 3-5) (1 mM) at days 1, 3, and
14.
Furthermore, the effect of salts and pH was investigated in the
self-assembly process. [WR]5 showed self-assembled structures
in phosphate buffered saline (PBS, pH 7.0) (Fig. 2e). The
aggregation was faster in PBS compared to an aqueous solution
resulting in the formation of a larger size of vesicles (500-1000
4 | Soft Matter, [year], [vol], 00–00

100

nm) after 12 days (Fig. 2f). This could be due to the presence of
different salts that can facilitate the self-assembly. CD also
revealed the development of additional positive band at 196 nm
in PBS. The pattern of structures formation has a resemblance
with surfactant-like linear peptides reported by Nagai et al.20
Moreover, it is well known that NaCl favors surfactant
aggregation.21 When PBS containing NaCl (167 mM) was
examined in the self-assembly of this peptide, the aggregation of
[WR]5 was accelerated. NaCl decreases the repulsive force
among the charged head groups, resulting in enhancement of
hydrophobic interactions between the peptides. However, in
acidic medium (0.02 N HCl), some irregular structures were
observed initially but longer incubation time led to degradation of
the structures (Fig. S5, Supporting Information).
In order to assess the different self-assembly behavior of
[WR]5 in water and PBS, turbidity measurements22 were carried
out to determine vesicle formation at 350 nm. Difference in
turbidity was clearly visible from the results. A sudden increase
in the absorbance was observed above certain concentrations in
both cases. Critical Aggregation Constant (CAC) values were
determined from the intersection point obtained by extrapolating
the lines. The CAC values for this peptide in water and PBS were
found to be 0.9 mM and 0.45 mM, respectively (Fig. S6,
Supporting Information), suggesting surfactant-like nature of the
peptide in the presence of salts.
Fluorescence studies were performed for [WR]4 to show the
aggregation of the peptide at concentrations above 1 mM (Fig.
S2) consistent with the data described in Fig. S6 for [WR]5. The
aggregation of [WR]4 was observed in a concentration-dependent
fluorescence study. At lower concentrations, the fluorescence
intensity was proportionally increased (excitation 280 nm,
emission 360 nm). However, the intensity remained constant at a
higher concentration of 1 mM (Fig. S2, Supplementary
Information).
As shown above, the self-assembly was promoted in the
presence of salts. Molecular modeling studies were used to gain
better insights of nanostructure formation with [WR]5 in the
presence of counterions. Initial coordinates for [WR]5 were
obtained using GAUSSVIEW.23 Ab initio Hartree Fock
molecular orbital calculations with complete geometry
optimizations were performed with 6-31G24 basis set on
monomer [WR]5 utilizing GAUSSIAN’03 software. Two
conformations were obtained (Fig. S7, Supporting Information).
The lowest energy conformation did not allow any intramolecular
H-bonding. Higher energy conformation (25 kCal/mol) shows
intramolecular H-bonding between cationic and neutral side
chains. Side chains have to reorganize for efficient intramolecular
H-bonding resulting in higher energy conformation. In the lowest
energy conformation tryptophan side chains are disposed
perpendicular to backbone. Higher energy conformation being
more planar seems more suited for stacking. Stacking efficiency
was explored utilizing supermolecule type intermolecular
interaction calculations. Stacking efficiency = Estacked supermolecule –
(Emonomer × no. of monomers + Ecounterion × no. of counterions).
[WR]5 is an amphiphilic peptide. Cationic side chains may
facilitate counterion assisted self-assembly. First, interaction of
cationic side chains with small fluoride ions was studied (Fig. S8,
Supporting Information). Fluoride counterions assisted self-

This journal is © The Royal Society of Chemistry [year]
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assembly propensity of [WR]5 system and resulted in nanotubular
formation (Fig. S9, Supporting Information). Then interaction of
trifluoroacetate ions (CF3COO-) with cationic side chain was
calculated, and counterion-mediated stacking was explored. The
data indicated that [WR]5 can undergo self-assembly
spontaneously in the presence of trifluoroacetate counterions.
Trifluoroacetate counterions are larger in size. Thus, nanotubular
stacking was not preferred. Instead, the system presented spiral
noncovalent association (Fig. 4), giving rise to nanostructure
formation. Longer period of self-assembly simulation generated
structures with larger size as observed in TEM and SEM
experiments. We assume that intramolecular along with
intermolecular interactions, such as hydrogen binding, π-π
interactions, and counterion interactions work cooperatively
during the self-assembly process of [WR]5. Intramolecular
hydrogen bonding between W and R residues results in the high
energy conformation which is suited for stacking hence it
indirectly helps. Intermolecular interaction is purely electrostatic
between cationic R residues and counteranions which may be
basically any anion small enough to squeeze between monomers
and interact efficiently. In [WR]5, self-assembly does not depend
mainly on diffusion of the peptide, but certainly depends on
diffusion of counterions. In the absence of any medium i.e.
without any counterions, [WR]5 show only minimal aggregation
as it is not thermodynamically favored.
We propose that the hydrophobic segments in the peptide
initialize the supramolecular self-assembly and drive the peptide
to form nanospherical water-filled structures. The positively
charged portion of the peptide containing arginine residues
orients to face the aqueous and counterion environment.
Moreover, the hydrophobic residues stabilize the nanostructure as
the particles become larger through inter- and intra-molecular
hydrogen bonding. Additionally, the relatively weaker hydrogen
bonded segments in the secondary structures facilitate the peptide
to manage the assemblies at extremely lower concentrations (e.g.
100 µM). As it is shown in Fig. 2c, increasing the hydrophobicity
character by increasing the number of tryptophan residues from 3
to 5 for [WR]5 induced the formation of completely different
secondary structure as it is shown by CD. However, as it is
exhibited in Fig. 3, the size distribution of [WR]5 is relatively
smaller than that of [WR]4 after 14 days showing that other
parameters are also involved in the self-assembly process.25
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Fig. 4. Self-assembled nanostructure formation of [WR]5 in the presence
of CF3COO- ions. Stacking efficiency is given in kCal/mol.

Additional molecular modeling studies were then conducted in
the
presence
of
a
1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC) membrane bilayer using SPC water
model. Membrane was set up by system builder module. Then
water was added. Whole system was subjected to simulated
annealing followed by molecular dynamics at room temp for 5 ns.
When the side view is observed carefully, it does show two
distinct surfaces. Results of 5 ns trajectory showed that [WR]5
dimer aligned at oil (mimicked by membrane)-water interface
with hydrophobic surface containing tryptophan residues towards
the hydrophobic residues in membrane, suggesting surfactant
property of the peptide (Fig. S10). The stability of system at the
interface and low RMSD for all heavy atoms with time indicated
successful simulation of mode of action for [WR]5 system as a
biosurfactant or peptide surfactant (pepfactant). At oil-water
interface mimicked by membrane-water interface in these
simulations, this aggregated supramolecular form stays as such
with hydrophobic groups towards membrane and hydrophilic
towards water indicating the type of micellar formation
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Fig. 5. Synthesized [WR]5 analogues.
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In general, the intrinsic properties of a peptide sequence
including hydrophobicity, charge, secondary structure propensity,
and sequence patterning are responsible for controlling the selfassembly process.26,27 Thus, in order to investigate the effect of
hydrophobicity and charge in the self-assembly process and to
gain further mechanistic insight into the packing of self-assembly
of [WR] series, a class of cyclic peptide analogues of [WR]5 was
designed rationally by using modified building blocks of arginine
and tryptophan (Fig. 5), and their self-assembly pattern was
investigated.
Modified [WR]5 analogues exhibited different morphologies
depending on the hydrophobicity and charge of the amino acids
in the structure of the peptides as shown by TEM observations.
To investigate the effect of hydrophobicity of tryptophan in the
self-assembly, a new building block N-methyl-L-tryptophan
(WMe) was used as the hydrophobic residue in place of
tryptophan. The resulting cyclic peptide [WMeR]5 showed
nanotubular structures instead of spherical vesicles as evidenced
by TEM (Fig. 6). Here, enhanced hydrophobicity of the peptide
and the absence of NH moiety of tryptophan played critical roles
in the self-assembly process.
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Fig. 6. TEM images of self-assembled structures of [WMeR]5 (2 mM in
water) after (A) 6 days and (B) 12 days. Individual nanotube structure is
shown in inset (scale: 100 nm).

self-assembly process, another analogue [WR(Me)2]5 was
synthesized by replacing the arginine with N,N-dimethylarginine
keeping tryptophan as a hydrophobic residue unchanged. Thus,
the hydrophilicity of the charged residues was reduced that
resulted in poor water solubility. Unlike the previous peptides,
this compound (1 mM aqueous solution) generated micelle-like
spherical nanostructures (Fig. S11, Supporting Information). It
was found that the compound did not exhibit any large vesicles
like [WR]5 even after prolonged incubation (25 days), presumably
due to the absence of one of free amine groups of guanidine.
These data suggest that this free amino group contributes to the
self-assembly process of [WR]5 possibly through hydrogen
bonding. On the other hand, a peptide containing both Nmethyltryptophan (WMe) and N,N-dimethylarginine (R(Me)2)
([WMeR(Me)2]5) did not produce any specific structures at 2 mM or
4 mM concentration. At higher concentration (4 mM),
[WMeR(Me)2]5 exhibited a few micelle-like nanostructures along
with patches of membrane-like sheets between the nanostructures
and copper grid during sample preparation (Fig. S12, Supporting
Information). This peptide might have undergone self-assembly
on the surface of copper grid by hydrophobic interactions to form
monolayer membranes, possibly due to the highly hydrophobic
nature of the amino acids.
The formation of nanotubes through the self-assembly of D,Lcyclic peptides has been previously reported.10 The backbonebackbone interactions between peptides were found to be critical
for the self-assembly of D,L-cyclic peptides. Our results indicated
that hydrophobicity and the charge were crucial for the selfassembled structure formation for these cyclic peptides, as they
were in the mechanism of linear surfactant-like peptides.11 Thus,
we compared the nanostructure formation between homochiral
[WR]5 with the corresponding heterochiral to evaluate the effect
of stereochemistry. Thus, D,L-cyclic peptide [WdR]5, where dR
is d-arginine, was designed and synthesized for the comparative
stereochemistry studies. Unlike the nanotube formation by D,Lcyclic peptides, [WdR]5 exhibited micelle like nanostructures
after prolonged incubation at room temperature (Fig. S13,
Supporting Information). The detailed mechanism of the selfassembly for these cyclic peptides requires further investigation
with modeling and simulation experiments.
Qualitative analysis of the conformation of these peptide
analogues was obtained by CD. CD spectra of aqueous solution
of the peptides [WMeR]5 and [WR(Me)2]5 at room temperature (Fig.
S14, Supporting Information) revealed two negative bands at
approximately 203 and 217 nm. This does not resemble either a
classic β-sheet or α-helical structures. Another analogue
[WMeR(Me)2]5 also showed similar bands, but with a lower
elipticity. These three peptide analogues, namely [WMeR]5,
[WR(Me)2]5 and [WMeR(Me)2]5, showed negative band at around
217 nm and positive band at around 229 nm, which are
characteristics of exciton coupling of tryptophan residues,
indicating the presence of stacking interactions. However,
[WdR]5 did not exhibit any characteristic signatures of exciton
coupling of tryptophan side chain, suggesting the absence of
stacking of indole rings.

To determine the role of positively-charged arginine in the
6 | Soft Matter, [year], [vol], 00–00
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2.2. Stabilization of Silver Nanoparticles by [WR]5
and Modified Analogues

5

10

15

20

25

30

35

40

45

50

55

We have previously reported the application of [WR]5 as a
nuclear targeting molecular transporter for a wide range of
cargos.16 It was found out that a physical mixture of [WR]5 and
HAuCl4 led to the formation of peptide-capped gold nanoparticles
and enhanced the cellular uptake of drugs significantly.28 We
investigated to determine whether [WR]5 can be used for the
stabilization of silver nanoparticles and proteins. Several methods
for the synthesis of silver nanoparticles have been previously
reported. However, the stabilization of silver nanoparticles is
required for various applications. The stabilizing agents (e.g.,
surfactants, polymer) prevent the particle aggregation by
protecting these particles by steric stabilization. Cationic
surfactants are commonly used as stabilizing agents in silver
nanoparticles synthesis.29 Accounting the above facts, we
postulated that [WR]5 could behave as a cationic surfactant.
In order to explore whether [WR]5 can mimic the role of
cationic surfactants in the synthesis of nanoparticles, a model
experiment was performed using silver nitrate (AgNO3) as a
source of Ag+ ion and sodium borohydride (NaBH4) as a reducing
agent in the presence and absence of the cyclic peptide. Sodium
borohydride was added into the equal volume mixture of cyclic
peptide [WR]5 (1 mM) and AgNO3 (2 mM) solution. To
demonstrate the role of cyclic peptide as stabilizer, sodium
borohydride was used in excess amount (8 mM). The resulting
mixture produced yellow color immediately, indicating the
formation of silver nanoparticles. UV-Vis spectra showed the
characteristic plasmon band of silver nanoparticles formation
with a band at 410 nm (Fig. 7A). The formation of spherical
silver nanoparticles was confirmed by TEM (Fig. 7B). In order to
monitor the stability of the silver colloid, absorption of the
colloid was measured after four weeks. The evolution of UV-Vis
spectra is shown in Fig. 7A (curve b). There was only a minor red
shift in peak position even after four weeks (curve c), confirming
the stability of the silver colloids. No extra peaks or shoulders
were developed even after one month, eliminating the possibility
of aggregation. On the contrary, when sodium borohydride was
added to AgNO3 (2 mM) solution in the absence of the peptide
(Fig. 7A, curve a), stable silver nanoparticles were not formed.
These data confirm the surfactant-like nature of the cyclic peptide
[WR]5. The stability of silver nanoparticles was also examined in
the presence of the corresponding linear peptide. The linear
peptide was not efficient in stabilizing silver nanoparticles (Fig.
S18).
The stabilization of silver nanoparticles with [WR]5 was
compared with a traditional surfactant (cetyltrimethylammonium
bromide, CTAB). CTAB is a well known cationic surfactant
which is used as a stabilizer in nanoparticle synthesis. It is
already reported in the literature that CTAB shows better
stabilizing effect at low concentration.30 The stability of silver
nanoparticles in the presence of CTAB was checked after 4 days,
and it showed aggregation of nanoparticles. The decrease in band
(~410 nm) intensity and development of extra band
approximately at 610 nm indicate particle aggregation (Fig. S19).
Traditional surfactant or some polymeric compounds form
micelles which are used to stabilize the metal nanoparticles.31,32
The micelles are porous cluster with deep water filled cavities. In
This journal is © The Royal Society of Chemistry [year]
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case of traditional surfactants, micelles control the shape of the
nanoparticles by trapping the metal ion and reagent in the small
cavities. Here, micelles formed by peptides, are water rich. Due
to self-assembly process, cyclic peptides initially form micelles
which stabilize the nanoparticles. Thus, when AgNO3 and peptide
solution are mixed, Ag+ ions may reside into the micelles. Once
NaBH4 is added, Ag+ ions are converted into Ag0 that remains
stable without any aggregation. Small surfactant-like peptides
surround the metal nanoparticles and protect them from
aggregation. TEM images shows clear layer of the peptide on
nanoparticle surface (Fig. S20). This follows the similar model
shown by a traditional surfactant.

Fig. 7. (A) UV-Vis spectra of yellow color silver nanoparticles solution in
the absence (a) and presence (b, c) of [WR]5 peptide and comparison of
the stability of silver nanoparticles in the presence of peptide after 30 min
reaction (curve b) and one month (curve c); (B) TEM image of silver
nanoparticles synthesized by sodium borohydride in the presence of
[WR]5.

The effect of the peptide concentration in stabilizing silver
nanoparticles was investigated by using different concentrations
of peptide. Visual observation showed that the typical color of
silver nanoparticles changed from pale yellow to dark yellow and
brown, respectively, indicating the alteration of nanoparticle
morphology in the presence of different concentrations of
peptide. This observation was consistent with UV-Vis
spectroscopy (Fig. S15, Supporting Information) that showed a
narrow band at 401 nm when 100 µM of the peptide was used. As
the concentration of the peptide was increased from 100 to 200
µM, the absorbance curve did not change significantly. However,
the absorbance band became short and shifted towards longer
wavelength when a peptide concentration of 500 µM was
employed, indicating the aggregation and formation of larger
particles. The absorbance band became broad and significantly
shorter at the peptide concentration of 1 mM. The broadening of
the band suggests wide distribution (higher dispersity) of particles
size. These results revealed that the optimization of the peptide
concentration is necessary to achieve narrower particle size
distribution. This pattern is similar to other synthesized
surfactant-stabilized silver nanoparticles.
To investigate whether the other synthesized cyclic peptide
analogues can show surfactant-like properties, they were explored
as stabilizing agents in the silver nanoparticles synthesis. Among
them, [WMeR]5 showed a great potential as a stabilizing agent.
Although it shows slight red shift (6 nm) in the band after one
week, but there is no sign of aggregation of silver nanoparticles
(Fig. 8A). This result supports the surfactant-like nature of
[WMeR]5. However, the intensity of absorbance was decreased in
the presence of [WR(Me)2]5 after 7 days (Fig. 8B), indicating the
Soft Matter, [year], [vol], 00–00 | 7

5

aggregation of nanoparticles. Furthermore, in the presence of
[WMeR(Me)2]5, the plasmon band of silver nanoparticles shifted (46
nm) significantly to longer wavelength indicating the formation
of large particles (Fig. 8C). Similar results were obtained for
[WdR]5 (Fig. 8D). This could be attributed to the irregular
structure formation by these peptides.
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Fig. 8. UV-vis spectra of silver nanoparticles in the presence of (A)
[WMeR]5, (B) [WR(Me)2]5, (C) [WMeR(Me)2]5, and (D) [WdR]5 at room
temperature after 15 min (a) and 7 days (b).
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Fig. 9. Enzymatic activity of GAPDH. Changes in fluorescence due to
NAD+ reduction are the result of GAPDH activity. (A) Enzymatic
activity shown till 30 min at room temperature; (B) Enzymatic activity
shown till 60 min at 50 ⁰C. (●) GAPDH enzyme in PBS, (■) GAPDH
enzyme in PBS in the presence of [WR]5 (100 µM), (▲) GAPDH enzyme
in PBS in the presence of [WR]5 (500 µM).

The presence of peptide-surfactant enhanced the activity of the
enzyme as described. Thus, it was essential to verify the influence
of the peptide on the stability of the enzyme. To this notion, the
activity of GAPDH was determined in the presence of the peptide
at 37 ⁰C and 50 ⁰C. The enzyme in the presence of the peptide
showed 2-fold enhanced activity compared to control one at 50
⁰C (Fig. 9B) and 37 ⁰C (Fig. S16, Supporting Information),
indicating enhanced stability of GAPDH enzyme in the presence
of the peptide-surfactant. These results suggest that this surfactant
peptide could be a promising additive for stabilizing other
biomacromolecules, such as membrane proteins.

2.3. Stabilization of Glyceraldehyde-3-Phosphate
Dehydrogenase (GAPDH) by [WR]5

3. Experimental

It is already known that surfactants influence the enzymatic
activities depending upon the interaction with the surface of the
enzymes.33 Thus, the capability of this surfactant-like peptide in
stabilizing biomacromolecules was investigated using
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a
model enzyme. The activity of GAPDH enzyme was determined
by using KDalert GAPDH assay kit. The KDalert GAPDH assay
determines the conversion of NAD+ to NADH by GAPDH in the
presence of phosphate and glyceraldehyde-3-phosphate (G-3-P).
Under the suggested assay conditions, the rate of NADH
production is proportional to the amount of GAPDH enzyme
present. To evaluate the effectiveness of the peptide in stabilizing
enzymatic activity, experiments were carried out by mixing the
enzyme with various peptide concentrations in phosphate
buffered saline (PBS, NaCl (167 mM), pH 7.0). GAPDH was
mixed in PBS as a control. The activity of the enzyme at different
time intervals in the presence and absence of the peptide was
measured using the fluorescence-based method. Plots were made
to show the increase in fluorescence due to NAD+ reduction vs
time. It was observed that enzyme containing 100 µM of [WR]5
showed significantly enhanced activity compared to the control
enzyme (Fig. 9A), suggesting surfactant-like nature of the
peptide. Moreover, the enzyme activity was reduced at higher
peptide concentration (500 µM), presumably due to the
denaturation of the enzyme, indicating the ionic nature of the
peptide-surfactant. A control experiment was also performed
without the enzyme to rule out any effect of the peptide in the
reduction process. Negligible fluorescence was recorded when
the peptide solution was mixed with other components in the
absence of the enzyme.

3.1. Synthesis of Cyclic Peptides
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The synthesis of cyclic peptides was carried out according to the
previously reported procedure by us.16 All reactions were carried
out in Bio-Rad polypropylene columns by shaking and mixing
using a Glass-Col small tube rotator in dry conditions at room
temperature unless otherwise stated. In general, all linear peptides
were synthesized by the solid-phase synthesis strategy employing
N-(9-fluorenyl)methoxycarbonyl (Fmoc)-based chemistry and
Fmoc-L-amino acid building blocks. 2-(1H−Benzotriazole-1-yl)1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) and
N,N-diisopropylethylamine (DIPEA) in N,N-dimethylformamide
(DMF) were used as coupling and activating reagents,
respectively. Fmoc-amino acid trityl chloride resins, 2chlorotrityl chloride resin, coupling reagents, and Fmoc-amino
acid building blocks were purchased from Chempep (Miami, FL).
Other chemicals and reagents were purchased from SigmaAldrich Chemical Co. (Milwaukee, WI). Fmoc deprotection at
each step was carried out using piperidine in DMF (20% v/v).
Side chain protected peptides were cleaved from the resins by
shaking the resins with a mixture of trifluoroethanol (TFE)/acetic
acid/dichloromethane (DCM) (2:2:6, v/v/v, 15 mL) for 2 h. The
resins were filtered off, and the liquid was evaporated to dryness
to get side-chain protected linear peptide. The cyclization of the
peptides was carried out in the presence of a mixture of 1hydroxy-7-azabenzotriazole (HOAt, 163.3 mg, 1.2 mmol) and
N,N′-diisopropylcarbodiimide (DIC, 187 µL, 1.2 mmol) in dry
DMF (100 mL), and dry DCM (40 mL) for 24 h. DMF and DCM
were evaporated. The side chain deprotection was carried with
trifluoroacetic acid (TFA)/thioanisole/anisole/1,2-ethanedithiol
This journal is © The Royal Society of Chemistry [year]
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(EDT) (90:5:2:3 v/v/v/v) for 2 h. The crude peptides were
precipitated by the addition of cold diethyl ether (75 mL, Et2O)
and purified by reversed-phase Hitachi HPLC (L-2455) on a
Phenomenex Prodigy 10 µm ODS reversed-phase column (2.1 cm
× 25 cm) with using a gradient system. The peptides were
separated by eluting the crude peptides at 10.0 mL/min using a
gradient of 0-100% acetonitrile (0.1% TFA) and water (0.1%
TFA) over 60 min, and then, they were lyophilized. The chemical
structure of [WR]4 was characterized by nuclear magnetic
resonance spectra (1H NMR) determined on a Varian NMR
spectrometer (500 MHz) as described previously.16 The chemical
structures of all final products were confirmed by a highresolution Biosystems QStar Elite time-of-flight electrospray
mass spectrometer. The purity of final products (>95%) was
confirmed by analytical HPLC. The analytical HPLC was
performed on the Hitachi analytical HPLC system on a C18
Shimadzu Premier 3 µm column (150 cm × 4.6 mm).
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N-(9-Fluorenylmethoxycarbonyloxy)succinimide (Fmoc-ONSu,
11.55 g, 0.034 mol) was added to a round bottom flask, dissolved
with 75 mL of DMF with constant stirring at 0 °C. 1-Methyl-Ltrypthophan (5 g, 0.22 mol) was added to sodium carbonate
solution (10%, 75 mL), and the mixture was stirred at room
temperature to form a suspension. The suspension prepared above
was added dropwise at 0 °C with constant stirring to the solution
of Fmoc-ONSu in DMF. The precipitate formed immediately.
The mixture was stirred for another 1 h and made at room
temperature. Acetone (80 mL) was added to the mixture and the
stirring continued overnight. The precipitate was removed by
filtration, and the pH of the filtrate was adjusted to 7.0 with HCl.
The solution was concentrated in a rotary evaporator. A 200 mL
of ethyl acetate was added to the mixture and resulted solution
was stirred for 6 h at room temperature. Ethyl acetate layer was
washed with 100 mL of 0.1N HCl two times and then with brine
(75 mL), and dried over anhydrous MgSO4 The solvent was
removed with rotary evaporator to yield crude creamy solid
compounds. The compound was re-crystallized in ethyl acetate to
afford 4 g of pure material, which was used without further
purification for the synthesis of cyclic peptides [WMeR]5,
[WR(Me)2]5, and [WMeR(Me)2]5 according to the previously reported
procedure.16
[FK]4: HR-MS (ESI-TOF, m/z): [M]+ calcd for C60H84N12O8,
1100.6535; found, 1100.5836 [M]+, 551.2918 [M + 2H]2+,
367.8752 [M + 3H]3+.
[AK]4: HR-MS (ESI-TOF, m/z): [M]+ calcd for C36H68N12O8,
796.5283; found, 796.4868 [M]+, 399.2434 [M + 2H]2+.
[CR]4: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C36H69N20O8S4, 1037.4490; found, 1037.4096 [M + H]+,
345.1323 [M + 3H]3+, 259.1024 [M + 4H]4+.
[FR]4: HR-MS (ESI-TOF) (m/z): [M]+ calcd for C60H84N20O8,
1212.6781; found, 1212.6052 [M]+, 607.3026 [M + 2H]2+,
405.5428 [M + 3H]2+, 304.1588 [M + 4H]3+.
[WR]3: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C51H67N18O6, 1027.5491; found, 1027.6030 [M + H]+.
[WR]4: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C68H89N24O8, 1369.7295; found, 1369.7934 [M + H]+, 685.3967
This journal is © The Royal Society of Chemistry [year]

[M + 2H]2+, 457.2696 [M + 3H]3+, 343.2066 [M + 4H]4+; FT-IR
of [WR]4 was carried out using Thermo-Nicolet 380 FT-IR
spectrophotometer using OMNIC software. FT IR (cm-1) (ATR):
1654, 1640.36, 1531.22, 1494.39, 1431.63, 1198.35, 1170.79,
1119.02, 837.31, 799.83, 745.55, 719.71.
[WR]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C85H111N30O10, 1711.9099; found, 1711.6974 [M + H]+, 571.5658
[M + 3H]3+, 428.9286 [M + 4H]4+, 343.1493 [M + 5H]5+.
[WMeR]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C90H121N30O10, 1781.9882; found, 1782.0165 [M + H]+, 594.6633
[M + 3H]3+, 446.4739 [M + 4H]4+, 357.4033 [M + 5H]5+.
[WR(Me)2]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C95H131N30O10, 1852.0664; found, 1852.1065 [M + H]+, [M +
2H]2+, 618.3545 [M + 3H]3+, 463.9962 [M + 4H]4+, 371.4213 [M
+ 5H]5+.
[WMeR(Me)2]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for
C100H141N30O10, 1922.1447; found, 1921.5000 [M + H]+,
483.9131 [M + 4H]4+, 383.6360 [M + 5H]5+.
[WdR]5: HR-MS (ESI-TOF) (m/z): [M]+ calcd for
C85H110N30O10, 1710.9021; found, 571.6383 [M + 3H]3+,
428.9571 [M + 4H]4+, 343.3879 [M + 5H]5+.

3.3. Transmission Electron Microscopy (TEM)
80

85

3.3.1. Conventional TEM
TEM sample was prepared by drop casting a 2 mM aqueous
solution (10 µL) onto the formvar coated carbon grid of mesh
size 300, which was allowed to sit for 2 min. Excess solvent was
carefully removed by capillary action (filter paper). Grids were
allowed to dry at room temperature for overnight and images
were taken using JEOL Transmission Electron Microscope
(Tokyo, Japan) maintained at 80 kv.

3.3.2. Negative Staining
90

After drop casting of peptide solution, grids were then stained
with uranyl acetate (20 µL) for 2 min. Excess stain was removed,
and the grids were allowed to dry for overnight. Images were
taken using JEOL Transmission Electron Microscope (Tokyo,
Japan) maintained at 80 kv.

3.4. Scanning Electron Microscopy (SEM)
95

100

SEM sample was prepared by drop casting a 2 mM aqueous
solution (10 µL) onto the mica surface. Mica surface was allowed
to dry at room temperature for overnight and analyzed in a Nova
NanoSEM 450 using the Directional Backscatter (DBS) Electron
Detector. All samples were imaged un-coated, in high vacuum
mode.

3.5. Circular Dichroism

105

CD spectra were recorded on a JASCO J-810 spectropolarimeter
using 1 mm path length cuvettes. The scan speed was 100
nm/min, and spectra were averaged over 8 scans. All samples
were tested at 25 °C. The sample concentration was 100 µM in
deionized water. The CD for background reference (water) was
measured and subtracted from the sample.
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3.6. Dynamic Light Scattering (DLS)
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Dynamic light scattering and zeta potential experiments were
conducted on a Malvern Instruments Zetasizer Nano ZS
(Worcestershire, UK). The machine was calibrated using a 60 nm
polystyrene standard. Each sample (1 mL, 100 µM) was loaded
into a cell, and the particle size and zeta potential were measured
simultaneously in triplicate. To determine the size distribution, 1
mL samples were placed in PCS1115 glass cuvettes and DLS was
performed at 25 °C at 173° backscatter angle with 120 s
equilibration time. The intensity-based z-averaged hydrodynamic
diameters reported based on 11 scans. To measure zeta potential
via electrophoretic mobility, the samples were added to a cuvette
equipped with copper chip. The measurement was conducted at
25 °C and 3 cycles were performed (30 data points per cycle).
DLS and zeta potential were conducted with 100 µM [WR]4 as a
stock solution.

3.7. Synthesis of Silver Nanoparticles

20

25

A stock solution of silver nitrate was mixed with NaBH4 in the
presence of cyclic peptides. Typically, 100 uL of 1 mM peptide
solution was mixed with 100 uL of 2 mM silver nitrate solution at
room temperature. Then 100 µL of 8 mM solution of NaBH4 was
added into the mixture to yield colloidal silver with a light
yellowish color. The UV-Vis spectra of the solution were taken
using SpectraMax M2 fluorescence spectrophotometer
(Molecular Devices, CA) at different time intervals.
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3.10. Fluorescence Spectroscopy
65

70

30

35

40

75

80

85

90

50

10 | Soft Matter, [year], [vol], 00–00

In summary, a new class of surfactant-like cyclic peptides was
reported. Among all the designed peptides, [WR]n (n = 3-5)
generated self-assembled vesicle-like nanostructures at room
temperature as shown by TEM, SEM, and/or DLS. A plausible
mechanistic insight of self-assembly of [WR]5 was investigated
by molecular modeling studies. Modified [WR]5 analogues, such
as [WMeR]5. [WR(Me)2]5, [WMeR(Me)2]5, and [WdR]5 exhibited
different morphologies than [WR]5 as shown by TEM. Surfactantlike cyclic peptide [WR]5 exhibited significant stabilizing effect
for generated silver nanoparticles and GAPDH activity. The data
suggested that surfactant cyclic peptides, [WR]5 and [WMeR]5,
could be promising materials for stabilization of silver
nanoparticles. These studies established a new class of surfactantlike cyclic peptides that self-assembled into nanostructures and
could have potential application for stabilizing of silver
nanoparticles and protein biomolecules.
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3.9. Molecular Modeling
Ab initio Hartree Fock molecular orbital calculations were
performed at the 6-31G basis set. Geometry of monomers was
completely optimized (all bond lengths, bond angles and dihedral
angles were allowed to relax without any constraint).
Intermolecular interaction calculations using supermolecule
approach were utilized to study stacking efficiency and
interaction with counterions present in the reaction medium.
Stacking efficiency = Estacked supermolecule – (Emonomer × no. of

FT-IR of [WR]4 was carried out using Thermo-Nicolet 380 FT-IR
spectrophotometer using OMNIC software. ATR-FTIR was used
to collect the spectra of the sample.

4. Conclusions

95
45

The steady-state fluorescence spectra were taken by a
SpectraMax M2 fluorescence spectrophotometer (Molecular
Devices, CA) in 96 well plate. The fluorescence of tryptophan
residues in samples were measured using excitation and emission
wavelength at 280 nm and 360 nm respectively. The
measurement was performed by excitation and emission slits with
a nominal band pass of 1 nm.

3.11. ATR-FTIR

3.8. Enzyme Activity Assay
The activity of GAPDH enzyme was measured using KDalert
GAPDH assay kit (Ambion, Austin, Texas). Briefly, 1 µL of
GAPDH enzyme was mixed with 99 µL PBS (pH 7.0) in an
eppendorf tube to create control enzyme solution of activity 0.26
U/ml. Same proportion of enzyme was mixed with different
concentration of peptide solution (100 µM, 500 µM and 1 mM) in
PBS. Then 10 µL of enzyme solutions from each tube was taken
in 96 well plates followed by the addition of 90 µL KDalert
master mix into it using multichannel pippettor. To determine the
activity of the enzyme, fluorescence of the solutions was
measured (Excitation: 560 nm, Emission: 590 nm). The reduction
of NAD+ to NADH was continuously monitored on a SpectraMax
M2 fluorescence spectrophotometer (Molecular Devices, CA) for
30 min at room temperature. Fluorescence measurements of
NADH production with control enzyme solution and enzyme in
100 µM and 500 µM peptide solutions were carried out in
triplicate. For thermal stability study, the fluorescence of the
solutions was measured for 60 min at 50 ⁰C.

monomers + Ecounterion × no. of counterions). Molecular modeling
studies without anion were conducted in the presence of a 1palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC)
membrane bilayer using SPC water model. Simulation was
performed at 300 K, and NPT ensemble was taken using
Martyna-Tobias-Klein Barostat method. Molecular dynamics
simulations were performed by Shaw's Desmond software.
Membrane was set up by system builder module. Then water was
added. Whole system was subjected to simulated annealing
followed by molecular dynamics at room temp for 5 ns.
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